Literature DB >> 20454821

Guillain-Barré syndrome after rtPA therapy for acute stroke.

A Bersano, D Santoro, A Prelle, S Lanfranconi, M Ranieri, C S Tadeo, N Bresolin, P L Baron.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20454821     DOI： 10.1007/s10072-010-0259-8

Source DB:  PubMed          Journal:  Neurol Sci        ISSN： 1590-1874            Impact factor:   3.307


× No keyword cloud information.
  13 in total

1.  Guillain-Barré syndrome after autologous peripheral blood stem cell transplantation for CML.

Authors:  J J Janssen; G Tissingh; G J Ossenkoppele
Journal:  Eur J Haematol       Date:  1999-11       Impact factor: 2.997

2.  Cell-mediated immunity in severely head-injured patients: the role of suppressor lymphocytes and serum factors.

Authors:  K B Quattrocchi; C H Miller; F C Wagner; S J DeNardo; G L DeNardo; K Ovodov; E H Frank
Journal:  J Neurosurg       Date:  1992-11       Impact factor: 5.115

3.  Guillain-Barré syndrome after treatment with streptokinase.

Authors:  D Barnes; R A Hughes
Journal:  BMJ       Date:  1992-05-09

4.  Guillain-Barré syndrome and head trauma. Case report.

Authors:  G R De Freitas; M R De Freitas; M C Ferreira
Journal:  Arq Neuropsiquiatr       Date:  1997-06       Impact factor: 1.420

Review 5.  Inflammatory cytokines in the nervous system: multifunctional mediators in autoimmunity and cerebral ischemia.

Authors:  G Stoll
Journal:  Rev Neurol (Paris)       Date:  2002-10       Impact factor: 2.607

6.  Immune activation in the peripheral blood of patients with acute ischemic stroke.

Authors:  Jun Yan; Judith M Greer; Kellie Etherington; Greg P Cadigan; Helen Cavanagh; Robert D Henderson; John D O'Sullivan; Jeyaraj D Pandian; Stephen J Read; Pamela A McCombe
Journal:  J Neuroimmunol       Date:  2008-12-05       Impact factor: 3.478

7.  The spectrum of antecedent infections in Guillain-Barré syndrome: a case-control study.

Authors:  B C Jacobs; P H Rothbarth; F G van der Meché; P Herbrink; P I Schmitz; M A de Klerk; P A van Doorn
Journal:  Neurology       Date:  1998-10       Impact factor: 9.910

Review 8.  Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome.

Authors:  Pieter A van Doorn; Liselotte Ruts; Bart C Jacobs
Journal:  Lancet Neurol       Date:  2008-10       Impact factor: 44.182

Review 9.  Guillain-Barré syndrome: epidemiology, pathophysiology and management.

Authors:  Satoshi Kuwabara
Journal:  Drugs       Date:  2004       Impact factor: 9.546

10.  Associated reactions during and immediately after rtPA infusion.

Authors:  W Linnik; J E Tintinalli; R Ramos
Journal:  Ann Emerg Med       Date:  1989-03       Impact factor: 5.721
View more
  1 in total

1.  Occurrence of Guillain-Barré syndrome as an immune mediated complication after thrombolysis with streptokinase for acute anterior wall myocardial infarction: a caution to be vigilant.

Authors:  Basant Kumar; Navin Agrawal; Soumya Patra; C N Manjunath
Journal:  BMJ Case Rep       Date:  2013-10-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.